Skip to content

Public FDA record

Z-0346-2020: The LivaNova VNS Therapy System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS T

Recall record Z-0346-2020 for LivaNova USA Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0346-2020
Company in FDA record
LivaNova USA Inc
FDA record creation date
Nov 7, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Lead impedance values reported by the affected VNS generator will be higher compared to those reported by previous models. This is due to a change in the timing of when affected VNS generator takes the lead impedance measurement during diagnostic testing. As a result, normal impedance ranges for the affected VNS generator have shifted relative to the existing thresholds of 600 - 5300 Ohms defined in labeling and as present in the programming software.

Source facts

Action
On 11/16/18, Medical Device Correction notices were mailed to treating and implanting physicians. The notice informed physicians that as indicated in the Physician's Manual, high lead impedance (greater-than-or-equal-to 5300 Ohms), in the absence of other device-related complications, is not an indication of a lead or generator malfunction. Existing recommendations, as described in the Physician's Manual, should still be followed. This will not impact the performance of the device, including the battery longevity and the ability to safely deliver therapy. The issue presents a risk of unnecessary surgery. Surgical interventions where high impedance could not be conclusively identified as being caused by a system malfunction or connector pin insertion issue have occurred in 0.24% of the potentially affected device population. Any patient implanted with a Model 1000 generator could potentially be affected by this issue. Patients implanted with 2.0 mm electrode leads (i.e. Model 30X-20) have a higher possibility of being affected by this issue than those patients implanted with 3.0 mm electrode leads (i.e. Model 30X-30), as the greater surface area of the 3.0 mm leads generally results in lower overall impedance results. Actions to be taken by the Physician 1. Continue to monitor patients and perform diagnostic testing at each visit. Information and recommendations regarding high and low impedance thresholds can be accessed in the VNS Therapy Physician's Manual If lead impedance is reported at, or above, the high impedance threshold (greater-than-or-equal-to 5300 Ohms): a. New implant patients: Perform an anteroposterior (AP) and lateral chest and neck X-ray and mail to Clinical Technical Support for X-ray review to assess proper lead pin insertion. b. Replacement patients: Perform an AP and lateral chest and neck X-ray and mail to Clinical Technical Support for X-ray review to assess proper lead pin insertion and for potential lead breaks. c. Contact
Initiated
2018-11-16
Root cause
Software design
Distribution
US: PA, WV, KY, NY, MD, VA, DC, NC, GA, SC, NJ, DE, MA, OH, RI, CT, ME, NH, VT, IL, WI, IN, MO, MI, MN, SD, ND, NE,KS, IA, TX, OK, TN, MS, AL, FL, LA, ID, MT, WA, OR, UT, AK, AZ, AZ , CO, WY, NM, CA, HI, AR. Foreign (OUS): Austria, Switzerland, Germany, Denmark, Spain, Finland, United Kingdom, Italy, Netherlands, Norway, Portugal, Sweden
Recall number
Z-0346-2020
Recall status
Open, Classified
CDRH record ID
171848
FDA record created
2019-11-07
Recall event number
82566

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗